Korea cuts price of ”new obesity treatment drug” Ugobi by 42%

Competition in the obesity treatment market is intensifying. Following Novo Nordisk's Ugovi, which was launched in Korea in October last year, Eli Lilly's Manjaro is scheduled to be launched next week.